Skip to content
10-K

Annual Report

NIAGEN BIOSCIENCE, INC. NAGE

0001386570-26-000013

← back to feed
Filed
Mar 4, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 3, 2026 80.08M sh
Shares Diluted FY 2025 · Dec 31, 2025 85.44M sh
Shares Diluted FY 2025 · Dec 31, 2024 78.13M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $251K
Stock Repurchased FY 2025 · Dec 31, 2024 $0
Operating Cash Flow FY 2025 · Dec 31, 2025 $13.5M
Operating Cash Flow FY 2025 · Dec 31, 2024 $12.11M
Stockholders Equity FY 2025 · Dec 31, 2025 $76.53M
Stockholders Equity FY 2025 · Dec 31, 2024 $46.09M
Stockholders Equity FY 2025 · Dec 31, 2023 $28.46M
Current Liabilities FY 2025 · Dec 31, 2025 $19.92M
Current Liabilities FY 2025 · Dec 31, 2024 $17.95M
Total Liabilities FY 2025 · Dec 31, 2025 $29.87M
Total Liabilities FY 2025 · Dec 31, 2024 $22.18M
Current Assets FY 2025 · Dec 31, 2025 $96.81M
Current Assets FY 2025 · Dec 31, 2024 $64.1M
Total Assets FY 2025 · Dec 31, 2025 $106.41M
Total Assets FY 2025 · Dec 31, 2024 $68.28M
Eps Diluted FY 2025 · Dec 31, 2025 $0.20
Eps Diluted FY 2025 · Dec 31, 2024 $0.11
Eps Basic FY 2025 · Dec 31, 2025 $0.22
Eps Basic FY 2025 · Dec 31, 2024 $0.11
Sga Expense FY 2025 · Dec 31, 2025 $27.06M
Sga Expense FY 2025 · Dec 31, 2024 $18.38M
Rd Expense FY 2025 · Dec 31, 2025 $6.33M
Rd Expense FY 2025 · Dec 31, 2024 $6.02M
Net Income FY 2025 · Dec 31, 2025 $17.38M
Net Income FY 2025 · Dec 31, 2024 $8.55M
Operating Income FY 2025 · Dec 31, 2025 $16.28M
Operating Income FY 2025 · Dec 31, 2024 $7.73M
Gross Profit FY 2025 · Dec 31, 2025 $83.19M
Gross Profit FY 2025 · Dec 31, 2024 $61.59M
Cost Of Revenue FY 2025 · Dec 31, 2025 $46.23M
Cost Of Revenue FY 2025 · Dec 31, 2024 $38.01M
Revenue FY 2025 · Dec 31, 2025 $129.42M
Revenue FY 2025 · Dec 31, 2024 $99.6M